Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Prostaglandins Leukot Essent Fatty Acids. 2011 Jun 12;85(2):53–60. doi: 10.1016/j.plefa.2011.05.001

Table 2.

Fatty acid contents of erythrocyte membrane phospholipids under the various diet conditions.

Commercial diet n-3PUFA diet n-6PUFA diet MUFA diet
n-9 series
Oleic Acid 17.5 ± 3.9a 23 ± 3.3b 19.6 ± 3.1a 26.1 ± 3.2b
n-6 series
LA 11 ± 0.65a 9.2 ± 1.2c 11.7 ± 0.9a 9.5 ± 1.3b
ARA 14.3 ± 2.1a 14.2 ± 1.1a 19.4 ± 1.3b 15.8 ± 1.2a
DPAn-6 0.56 ± 0.07b 0.41 ± 0.08a 1.22 ± 0.2c 1.03 ± 0.2c
n-3 series
ALA 0.17 ± 0.04a 0.37 ± 0.16b 0.04 ± 0.02c 0.04 ± 0.02c
EPA 0.36 ± 0.02a 0.63 ± 0.07b 0.06 ± 0.02d 0.08 ± 0.02c
DPAn-3 0.53 ± 0.2a 0.75 ± 0.1b 0.19 ± 0.03d 0.33 ± 0.04c
DHA 5.79 ± 0.9a 5.79 ± 0.9a 3.79 ± 0.6b 4.06 ± 0.7b
n-6/n-3 ratio
ARA/DHA 2.57 ± 0.6a 2.45 ± 0.2a 5.14 ± 0.3c 3.92 ± 0.3b

Note: Results are means ± SEM and are expressed as percents of the total fatty acid content of erythrocyte membrane phospholipids. Distinct and similar superscript letters (a, b, c and/or d) within a same horizontal line indicate significant (p<0.01) and not significant differences between dietary groups towards the considered fatty acid, respectively. Abbreviations are: LA, linoleic acid; ARA, arachidonic acid; DPAn-6, docosapentaenoic acid of the n-6 series; ALA, alpha-linolenic acid; EPA, eicosapentanoic acid; DPAn-3, docosapentaenoic acid of the n3 series, DHA, docosahexaenoic acid. Diets have been defined in the text and in Table 1 and have been given to mice for a period 30 days before analyses of erythrocyte membrane phospholipids. Contents in phospholipid saturated fatty acids are 100% from which are withdrawn percentages of phospholipid unsaturated fatty acids given in the table.